- U.S. Families Spend Over $3 Billion Each Year on OTC Cold Remedies -
NEW YORK, Nov. 11, /PRNewswire/ -- America is about to be hit with runny noses, sore throats and coughs, but recently a new, naturally safe solution has been introduced in the U.S. that is clinically proven to shorten the duration and reduce the severity of the common cold.
Zucol, a naturally-safe cold remedy produced by German pharmaceutical company, Schwabe, uses as its active ingredient an extract of pelargonium sidoides, which is one of the most researched plant-based pharmaceutical ingredients. Grown in South Africa, pelargonium has been used for generations as a remedy throughout Europe and Africa. The benefits of pelargonium have been featured in several U.S. medical journals including the American Family Physician and The Journal of Family Practice.
"For hundreds of years African Zulu tribes have used pelargonium sidoides preparations to treat coughs and upper respiratory symptoms, and it is the top-selling active ingredient for upper respiratory tract infections sold in Germany and most of Europe. It was only a matter of time that Zucol would arrive in the United States," said David Gumner, Vice President Mass Market at Nature's Way, Schwabe's U.S. subsidiary. "Extensive clinical research has proven the safety and efficacy of pelargonium, which justifies its use to reduce the need for typical OTC medications that merely mask symptoms of the common cold."
Zucol is produced according to exacting FDA-drug standards and is approved in the U.S. for the treatment of colds and upper respiratory tract infections related to the common cold.
Taken at the earliest signs of a cold, Zucol has been proven to end
cold symptoms sooner and reduce the likelihood of secondary infections. The
natural active ingredient in Zucol has been the subject of 18 published
clinical studies involving over 2,500 patients. These studies concluded
that cold sufferers were able to
'/>"/>
| SOURCE Zucol Copyright©2008 PR Newswire. All rights reserved |